Pharmaron Beijing (300759.SZ) Earnings Analysis
Pharmaron Beijing (300759.SZ) next reports earnings on 2026-08-31, consensus EPS 0.25 CNY. Last quarter (2026-03-30) it beat with EPS 0.3 CNY vs 0.28 CNY est (+7.1%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E 40.63.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 300759.SZ next report earnings?
| Next earnings date | 2026-08-31 |
|---|---|
| Consensus EPS estimate | 0.25 CNY |
| Revenue estimate | 3.85B |
300759.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-30 | 0.3 CNY | 0.28 CNY | +7.1% | Beat |
| 2025-08-21 | 0.2197 CNY | 0.2447 CNY | -10.2% | Miss |
| 2025-04-27 | 0.17 CNY | 0.2 CNY | -15% | Miss |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
300759.SZ valuation and analyst view
| Trailing P/E | 40.63 |
|---|---|
| Trailing EPS | 0.93937 CNY |
| Price / book | 4.27 |
| Dividend yield | 0.51% |
| Market cap | 58.74B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Pharmaron Beijing (300759.SZ)'s next earnings date?
Pharmaron Beijing is next scheduled to report on 2026-08-31, with a consensus EPS estimate of 0.25 CNY and revenue estimate of 3.85B.
Did 300759.SZ beat earnings last quarter?
In its 2026-03-30 report, 300759.SZ posted EPS of 0.3 CNY versus a 0.28 CNY estimate — a beat of 7.1%.
What is 300759.SZ's earnings track record?
Over the last 3 reported quarters with consensus data, 300759.SZ beat estimates 1 times (33%).
What is 300759.SZ's current P/E ratio and EPS?
300759.SZ trades at a trailing P/E of 40.63 on trailing EPS of 0.9393658860509609 CNY.
What do analysts rate 300759.SZ?
300759.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.